Effect of cimicifuga racemosa on menopausal syndrome caused by LHRH-a in breast cancer
-
Add time:08/10/2019 Source:sciencedirect.com
Ethnopharmacological relevanceCimicifuga racemose is previously proved effective on nature menopausal syndrome (MPS). However, its clinical value in treating with MPS induced by luteinizing-hormone releasing hormone analogue (LHRH-a) therapy of pre-/peri-menopausal breast cancer patients is still unknown.
We also recommend Trading Suppliers and Manufacturers of LHRH, His(6)-N-Et-ProNH2(9)- (cas 132461-43-9). Pls Click Website Link as below: cas 132461-43-9 suppliers
Prev:Theoretical characterization of (CuF)n (n = 1–12) clusters
Next:Enhanced cellular uptake of LHRH-conjugated PEG-coated magnetite nanoparticles for specific targeting of triple negative breast cancer cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles08/14/2019
- Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers08/13/2019
- LHRH-targeting surface-enhanced Raman scattering tags for the rapid detection of circulating tumor cells08/12/2019
- Enhanced cellular uptake of LHRH-conjugated PEG-coated magnetite nanoparticles for specific targeting of triple negative breast cancer cells08/11/2019
